Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis

被引:55
作者
Houghton, Damon E. [1 ,2 ]
Alsawas, Mouaz [3 ]
Barrioneuvo, Patricia [3 ]
Tello, Mouaffaa [3 ]
Farah, Wigdan [3 ]
Beuschel, Brad [3 ]
Prokop, Larry J. [5 ]
Layton, J. Bradley [4 ]
Murad, M. Hassan [3 ]
Moll, Stephan [6 ]
机构
[1] Mayo Clin, Dept Cardiovasc Dis, Div Vasc Med, 200 1st St SW, Rochester, MN 55905 USA
[2] Dept Internal Med, Div Hematol Oncol, 200 1st St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Evidence Based Practice Ctr, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, 200 1st St SW, Rochester, MN 55901 USA
[4] RTI Hlth Solut, Res Triangle Pk, NC 27709 USA
[5] Mayo Clin Lib, 200 1st St SW, Rochester, MN 55901 USA
[6] Univ N Carolina, Sch Med, Dept Med, Div Hematol Oncol, Chapel Hill, NC USA
关键词
Testosterone; Thrombosis; Venous thromboembolism; Hypercoagulability; CARDIOVASCULAR RISK-FACTORS; QUALITY-OF-LIFE; ANDROGEN DEFICIENCY; SOLUTION; 2-PERCENT; THROMBOTIC EVENTS; BODY-COMPOSITION; HYPOGONADAL MEN; DOUBLE-BLIND; SEX DRIVE; ASSOCIATION;
D O I
10.1016/j.thromres.2018.10.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Testosterone prescribing for men has dramatically increased, and there have been concerns about inappropriate use and adverse events. While regulatory bodies have warned about increased risk of venous thromboembolism (VTE), published clinical data supporting an increased risk for VTE are limited. Objective: To conduct a systematic review of studies examining the association between testosterone therapy in men and VTE. Methods: Comprehensive searches of multiple databases were performed from inception through October 3rd, 2018. Randomized control trials (RCTs) and observational studies examining the association between exogenous testosterone (any route) and VTE. Study selection and data extraction were performed by two independent investigators. Random-effect model meta-analyses were used to estimate pooled odds ratios (OR) and 95% confidence intervals (CIs). Heterogeneity among studies was evaluated using the I-2 statistic. Risk of bias was assessed using the Cochrane and Newcastle-Ottawa tools. Results: Six RCTs (n = 2236) and 5 observational studies (n = 1,249,640) were included. Five RCTs were performed in men with documented hypogonadism. The observational studies included: 2 case-control studies, 2 retrospective cohorts, and 1 retrospective cohort with a nested case-control study. There was no evidence of a statistically significant association between VTE and testosterone (OR 1.41, 95% CI 0.96-2.07). Heterogeneity was high (I-squared = 84.4%). The association remained nonsignificant when the analysis was stratified by study design: RCTs (2.05, 95% CI 0.78-5.39); cohort (1.06, 95% CI 0.85-1.33); and case-control (1.34, 95% CI 0.78-2.28). The overall risk of bias was moderate. Conclusions: The current evidence is of low certainty but does not support an association between testosterone use and VTE in men.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 54 条
[1]   TESTOSTERONE INCREASES HUMAN PLATELET THROMBOXANE A(2) RECEPTOR DENSITY AND AGGREGATION RESPONSES [J].
AJAYI, AAL ;
MATHUR, R ;
HALUSHKA, PV .
CIRCULATION, 1995, 91 (11) :2742-2747
[2]  
[Anonymous], 2014, FDA ADD GEN WARN TES
[3]  
[Anonymous], 1986, HEPATOLOGY, V6, P807
[4]  
Baillargeon J., 2013, JAMA INTERN MED, V173, P1038
[5]   Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy [J].
Baillargeon, Jacques ;
Urban, Randall J. ;
Morgentaler, Abraham ;
Glueck, Charles J. ;
Baillargeon, Gwen ;
Sharma, Gulshan ;
Kuo, Yong-Fang .
MAYO CLINIC PROCEEDINGS, 2015, 90 (08) :1038-1045
[6]   A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up [J].
Behre, Hermann M. ;
Tammela, Teuvo L. J. ;
Arver, Stefan ;
Tolra, Josep R. ;
Bonifacio, Vincenzo ;
Lamche, Michael ;
Kelly, Judy ;
Hiemeyer, Florian ;
Giltay, Erik J. ;
Gooren, Louis J. .
AGING MALE, 2012, 15 (04) :198-207
[7]   Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline [J].
Bhasin, Shalender ;
Cunningham, Glenn R. ;
Hayes, Frances J. ;
Matsumoto, Alvin M. ;
Snyder, Peter J. ;
Swerdloff, Ronald S. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06) :2536-2559
[8]   Hematocrit and risk of venous thromboembolism in a general population. The Tromso study [J].
Braekkan, Sigrid K. ;
Mathiesen, Ellisiv B. ;
Njolstad, Inger ;
Wilsgaard, Tom ;
Hansen, John-Bjarne .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02) :270-275
[9]   9-Month Efficacy and Safety Study of Testosterone Solution 2% for Sex Drive and Energy in Hypogonadal Men [J].
Brock, Gerald ;
Heiselman, Darell ;
Knorr, Jack ;
Ni, Xiao ;
Kinchen, Kraig .
JOURNAL OF UROLOGY, 2016, 196 (05) :1509-1515
[10]   Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study [J].
Brock, Gerald ;
Heiselman, Darell ;
Maggi, Mario ;
Kim, Sae Woong ;
Rodriguez Vallejo, Jose M. ;
Behre, Hermann M. ;
McGettigan, John ;
Dowsett, Sherie A. ;
Hayes, Risa P. ;
Knorr, Jack ;
Ni, Xiao ;
Kinchen, Kraig .
JOURNAL OF UROLOGY, 2016, 195 (03) :699-705